Glenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology. The company has four research and development centres, ten world‐class manufacturing facilities spread across five continents, and operations in over eighty countries. Glenmark Pharmaceuticals and its fully owned US subsidiary Ichnos Sciences together have formed an alliance ‘Ichnos Glenmark Innovation’ to use different modalities, technologies and combined expertise to treat cancer.